Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab +/- Bendamustine in MCL
NCT01437709Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2011
- Primary completion
- Sep 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in mantle cell lymphoma (MCL), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 2011; status: completed.
02
Drugs
ofatumumab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01437709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437709.